FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $637,000 | +422.1% | 10,885 | +427.1% | 0.14% | +264.9% |
| Q3 2021 | $122,000 | -85.6% | 2,065 | -78.9% | 0.04% | -84.8% |
| Q2 2021 | $850,000 | +51.8% | 9,792 | +44.2% | 0.24% | +28.4% |
| Q1 2021 | $560,000 | -16.3% | 6,792 | -7.6% | 0.19% | -12.0% |
| Q4 2020 | $669,000 | -46.6% | 7,352 | -76.5% | 0.22% | -43.2% |
| Q3 2020 | $1,252,000 | +51.4% | 31,317 | +30.0% | 0.38% | +61.7% |
| Q2 2020 | $827,000 | – | 24,092 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |